Business Description
SeaStar Medical Holding Corp
NAICS : 325412
SIC : 2834
ISIN : US81256L1044
Share Class Description:
ICU: Ordinary SharesDescription
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.24 | |||||
Equity-to-Asset | -0.58 | |||||
Debt-to-Equity | -0.91 | |||||
Debt-to-EBITDA | -0.12 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -14.7 | |||||
3-Year FCF Growth Rate | -2.6 | |||||
3-Year Book Growth Rate | 62.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.32 | |||||
9-Day RSI | 47.44 | |||||
14-Day RSI | 48.4 | |||||
6-1 Month Momentum % | -70.69 | |||||
12-1 Month Momentum % | -71.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.68 | |||||
Quick Ratio | 0.68 | |||||
Cash Ratio | 0.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -55.4 | |||||
Shareholder Yield % | -37.02 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -875.83 | |||||
ROIC % | -203.61 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.69 | |||||
EV-to-EBITDA | -0.69 | |||||
EV-to-FCF | -1.97 | |||||
Earnings Yield (Greenblatt) % | -144.93 | |||||
FCF Yield % | -45.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ICU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SeaStar Medical Holding Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -25.435 | ||
Beta | 0 | ||
Volatility % | 247.78 | ||
14-Day RSI | 48.4 | ||
14-Day ATR ($) | 1.635409 | ||
20-Day SMA ($) | 7.88366 | ||
12-1 Month Momentum % | -71.65 | ||
52-Week Range ($) | 3.25 - 42.9225 | ||
Shares Outstanding (Mil) | 3.22 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SeaStar Medical Holding Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SeaStar Medical Holding Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
SeaStar Medical Holding Corp Frequently Asked Questions
What is SeaStar Medical Holding Corp(ICU)'s stock price today?
The current price of ICU is $7.79. The 52 week high of ICU is $42.92 and 52 week low is $3.25.
When is next earnings date of SeaStar Medical Holding Corp(ICU)?
The next earnings date of SeaStar Medical Holding Corp(ICU) is 2024-08-16 Est..
Does SeaStar Medical Holding Corp(ICU) pay dividends? If so, how much?
SeaStar Medical Holding Corp(ICU) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |